Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)

(2016) Phoebe Rich et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

(2015) Iain B McInnes et al.   LANCET

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis

(2014) Muhammad Haroon et al.   ANNALS OF THE RHEUMATIC DISEASES

Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

(2014) Lihi Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

(2014) Arthur Kavanaugh et al.   ANNALS OF THE RHEUMATIC DISEASES

Updated Guidelines for the Management of Axial Disease in Psoriatic Arthritis

(2014) P. Nash et al.   JOURNAL OF RHEUMATOLOGY

Treatments for Nail Psoriasis: A Systematic Review by the GRAPPA Nail Psoriasis Work Group

(2014) A. W. Armstrong et al.   JOURNAL OF RHEUMATOLOGY

Systematic Review of Treatments for Psoriatic Arthritis: 2014 Update for the GRAPPA

(2014) L. C. Coates et al.   JOURNAL OF RHEUMATOLOGY

Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review

(2014) W.-H. Boehncke et al.   JOURNAL OF RHEUMATOLOGY

Comprehensive Treatment of Dactylitis in Psoriatic Arthritis

(2014) S. Rose et al.   JOURNAL OF RHEUMATOLOGY

Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations

(2014) A. Ogdie et al.   JOURNAL OF RHEUMATOLOGY

Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

(2014) M. L. Acosta Felquer et al.   JOURNAL OF RHEUMATOLOGY

Systematic Review of Treatment Effectiveness and Outcome Measures for Enthesitis in Psoriatic Arthritis

(2014) A.-M. Orbai et al.   JOURNAL OF RHEUMATOLOGY

Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

(2014) Mark G. Lebwohl et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial

(2014) C. Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)

(2013) Elke Theander et al.   ANNALS OF THE RHEUMATIC DISEASES

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

(2013) Matteo Nicola Dario Di Minno et al.   ANNALS OF THE RHEUMATIC DISEASES

Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis

(2013) William Tillett et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

(2013) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologic discontinuation studies: a systematic review of methods

(2013) Kazuki Yoshida et al.   ANNALS OF THE RHEUMATIC DISEASES

Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1

(2013) P. Rich et al.   BRITISH JOURNAL OF DERMATOLOGY

Infectious, Oncologic, and Autoimmune Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting

(2013) A. W. Armstrong et al.   JOURNAL OF RHEUMATOLOGY

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

(2013) Dominique Baeten et al.   LANCET

Enthesitis in psoriatic arthritis

(2013) Lazaros I. Sakkas et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis

(2012) Matteo Nicola Dario di Minno et al.   ARTHRITIS CARE & RESEARCH

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

(2010) Philip Mease et al.   ARTHRITIS AND RHEUMATISM

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES